Covered recipient · General Payments record
ELIA N ESCANAME
Allopathic & Osteopathic Physicians Pediatrics Pediatric Endocrinology
General Payments · PY2018–2024
$1,626.52
- Reported across 64 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $700.54 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $287.63 | 6 |
| Ascendis Pharma Inc | $137.22 | 6 |
| TOLMAR, INC. | $68.14 | 4 |
| Abbott Laboratories | $54.39 | 3 |
| DEXCOM, INC. | $48.95 | 2 |
| Kyowa Kirin, Inc. | $32.57 | 2 |
| BETA BIONICS, INC. | $24.80 | 1 |
| Insulet Corporation | $17.61 | 1 |
| Endo USA, Inc. | $15.02 | 1 |
| Azurity Pharmaceuticals, Inc. | $14.21 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $17.26 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125300555 | CMS |
| Abbott Laboratories | $18.89 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125300557 | CMS |
| Abbott Laboratories | $18.24 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125300559 | CMS |
| Ascendis Pharma Inc | $26.19 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133844394 | CMS |
| Ascendis Pharma Inc | $26.83 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133845677 | CMS |
| Ascendis Pharma Inc | $21.18 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133846209 | CMS |
| Ascendis Pharma Inc | $23.05 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133847386 | CMS |
| Ascendis Pharma Inc | $19.21 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133848867 | CMS |
| Ascendis Pharma Inc | $20.76 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133850428 | CMS |
| Azurity Pharmaceuticals, Inc. | $14.21 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134005489 | CMS |
| BETA BIONICS, INC. | $24.80 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087873607 | CMS |
| Dexcom, Inc. | $24.32 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153298139 | CMS |
| Dexcom, Inc. | $24.63 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153298141 | CMS |
| Endo USA, Inc. | $15.02 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138580121 | CMS |
| Insulet Corporation | $17.61 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116808361 | CMS |
| Kyowa Kirin, Inc. | $13.21 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127029341 | CMS |
| Kyowa Kirin, Inc. | $19.36 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127029343 | CMS |
| Novo Nordisk Inc | $11.11 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096656079 | CMS |
| Novo Nordisk Inc | $122.07 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097431004 | CMS |
| Novo Nordisk Inc | $110.20 | 04/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096665861 | CMS |
| Novo Nordisk Inc | $24.35 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096902407 | CMS |
| Novo Nordisk Inc | $7.37 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096839969 | CMS |
| Novo Nordisk Inc | $12.53 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096591526 | CMS |
| Tolmar, Inc. | $20.11 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138712478 | CMS |
| Tolmar, Inc. | $17.00 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138711512 | CMS |
| Tolmar, Inc. | $15.40 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138711514 | CMS |
| Tolmar, Inc. | $15.63 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138711510 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.